Skip to main content

Table 2 SerOzNET blood sampling schedule

From: Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)

Week (W) and day (D) of trial

Pfizer

3-week interval

Astra Zeneca

6-week interval

Astra Zeneca

12-week interval

Moderna

4-week interval

*W0 D0 (− 7)

Baseline

Baseline

Baseline

Baseline

W3 D21 (± 3)

2nd dose

 

D21 post 1st dose

 

W4 D28 (± 3)

   

2nd dose

W6 D42 (± 3)

 

2nd dose

  

W7 D49 (± 1)

1 M post 2nd dose

   

W8 D56

   

1 M post 2nd dose

W10 D70 (± 1)

 

1 M post 2nd dose

  

W12 D84 (± 7)

  

2nd dose

 

W15 D105 (± 7)

*3 M post 2nd dose

   

W16 D112 (± 1)

  

1 M post 2nd dose

3 M post 2nd dose

W18 D126 (± 7)

 

3 M post 2nd dose

  

W24 D168 (± 7)

  

3 M post 2nd dose

 

W27 D189 (± 7)

6 M post 2nd dose

   

W28 D196 (± 7)

   

6 M post 2nd dose

  1. Additional vaccines can be added when available
  2. D day, W week, M month